Combined thiazolidinedione-metformin treatment synergistically improves insulin signalling to insulin receptor substrate-1-dependent phosphatidylinositol 3-kinase, atypical protein kinase C and protein kinase B/Akt in human diabetic muscle (Q33643662)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combined thiazolidinedione-metformin treatment synergistically improves insulin signalling to insulin receptor substrate-1-dependent phosphatidylinositol 3-kinase, atypical protein kinase C and protein kinase B/Akt in human diabetic muscle |
scientific article |
Statements
1 reference
Combined thiazolidinedione-metformin treatment synergistically improves insulin signalling to insulin receptor substrate-1-dependent phosphatidylinositol 3-kinase, atypical protein kinase C and protein kinase B/Akt in human diabetic muscle (English)
1 reference
N Temofonte
1 reference
M P Sajan
1 reference
S Nimal
1 reference
T Pastoor
1 reference
C Fumero
1 reference
L Casaubon
1 reference
J L Powe
1 reference
M L Standaert
1 reference
R V Farese
1 reference
30 October 2008
1 reference
1 reference
Identifiers
1 reference